Metabolomics study in a group of Parkinson’s disease patients from Northern India
Objective: To do (1) H NMR study in a group of Parkinson’s disease patients, disease controls, viz. multiple system atrophy (MSA) and progressive supra nuclear…Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson’s disease and multiple system atrophy
Objective: To compare the features of urinary dysfunction in Progressive supranuclear palsy (PSP) with those of idiopathic Parkinson’s disease (IPD) and multiple system atrophy (MSA). Background:…Rolipram, a PDE-IV inhibitor protects against experimental Parkinsonism in mice
Objective: Rolipram, a specific inhibitor of the phosphodiesterase IV (PDE IV), has recently been shown to exert neuroprotective effects in an Alzheimer transgenic mouse model…Neuropsychiatric and Cognitive Predictors of Early Diagnosis of Progressive Supranuclear Palsy
Objective: To define differences of neuropsychiatric and neuropsychological profile among Progressive Supranuclear Palsy (PSP) -Richardson syndrome (PSP-RS), PSP-parkinsonism (PSP-P), and Parkinson’s disease (PD), in order…Anatomical predictors of survival in PSP: thalamic collapse towards the end of life
Objective: To correlate anatomical changes with time to death in PSP. Background: Many advances have been made in progressive supranuclear palsy (PSP) since it was first described…Long-term Parkinson’s disease progression in PIGD and TD subtypes in the PPMI cohort
Objective: Analyze the disease progression and time of therapy initiation for tremor dominant (TD) and postural instability gait disorder (PIGD) subtypes in the PPMI cohort.…Clinicopathological analysis of corticobasal syndrome: a retrospective study
Objective: Predicting underlying pathology in CBS. Background: Corticobasal syndrome (CBS) is pathologically heterogeneous. CBS is one of the clinical phenotypes of corticobasal degeneration (CBD) but may…Secondary Vascular Parkinsonism in Uzbekistan: Hormonal Pathogenetic Effects and Vascular-Immunological Basics.
Objective: We aimed to analyze the PD related hormonal factors and VP hormonal endothelial factors. Background: As we know the Vascular Parkinsonism (VP) and Symptomatic…Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study
Objective: To characterize the progression of cognitive decline and compare the neuropsychological 15-month profile across PSP, MSA and PD. Background: Cognitive impairments are frequently reported in…Causes, Complications and Outcomes of Hospitalization in Patients with Dementia with Lewy Bodies
Objective: To identify causes, complications and outcomes of hospitalization in patients with dementia with Lewy bodies (DLB). Background: Hospitalization is a known contributor to morbidity…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.